Quanterix - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeQuanterix
Quanterix logo

Quanterix

0 followers

QTRX

Performance

About Quanterix

Quanterix is a biotechnology company that develops ultrasensitive biomarker detection technology for precision health research and clinical applications. It offers Simoa® digital immunoassay instruments, a broad menu of assay kits, and custom assay development services, enabling researchers to quantify low-abundance proteins across neurology, oncology, cardiology, immunology/inflammation, and infectious disease. Headquartered in Massachusetts with a global footprint, Quanterix focuses on enabling early disease detection, prognosis, and monitoring through highly sensitive biomarker measurements.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Erica Bell

Chief People Officer

Michael Miller

Chief Operating Officer

Everett Cunningham

Chief Executive Officer

Naren Bhat

SVP, Corporate Development & Strategy

Daniel Char

Chief Legal Officer

Key Facts

HQ Location

Billerica, United States

Founded

2007

Employees

201 - 500

Status

Public

Website

https://quanterix.com